17 results
PRE 14A
ATHA
Athira Pharma Inc
28 Mar 24
Preliminary proxy
8:47am
and ethnicity to seek to ensure that there is diversity of thought among our directors. We also require training and compliance with other corporate policies
DFAN14A
EX-99.3
Kayne Richard A
22 Apr 22
Additional proxy materials by non-management
10:07am
a CEO in these critical years on training wheels. Unfortunately, a band aid like a management coach is not going to fool anybody, least of all
DFAN14A
EX-99.1
ATHA
Athira Pharma Inc
13 Apr 22
Additional proxy materials by non-management
5:29pm
) and completed my postdoctoral training in neurochemistry at the Roche Institute of Molecular Biology. I have published more than 200 peer reviewed papers
8-K
EX-99.1
co5eu7eyo3g 4szt
21 Mar 22
Athira Pharma Announces Appointment of Dr. Michael A. Panzara to its Board of Directors
7:21am
DEF 14A
f4ij9y
16 Apr 21
Definitive proxy
6:02am
10-K
onbp2vy dhk
25 Mar 21
Annual report
12:00am
424B4
2ulcjtu
21 Jan 21
Prospectus supplement with pricing info
12:00am
DRS
kf6ltert1ukx
6 Jan 21
Draft registration statement
12:00am
424B4
os7s 53dobc
18 Sep 20
Prospectus supplement with pricing info
4:05pm
S-1
3w7j0c4
26 Aug 20
IPO registration
5:25pm
DRS
z8wwcrwgceljwr9 2g
24 Jul 20
Draft registration statement
12:00am
- Prev
- 1
- Next